RNAC Iron Condor Strategy
RNAC (Cartesian Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in Phase I clinical trial to enhance the treatment of methylmalonic acidemia. It is also developing biologic therapies, such as SEL-212 that is in Phase III clinical trials for the treatment of chronic refractory gout; and product candidates to treat IgA-mediated diseases, including IgA nephropathy, linear IgA bullous dermatitis, IgA pemphigus, and Henoch-Schonlein purpura. In addition, the company is developing gene therapies comprising for the treatment of pompe disease, duchenne muscular dystrophy, limb-girdle muscular dystrophy, lysosomal storage disorder, and other autoimmune diseases. Further, it develops tolerogenic therapies to treat autoimmune diseases. The company has license and collaboration agreements with Ginkgo Bioworks Holdings, Inc.; Genovis AB (publ.); Cyrus Biotechnology, Inc.; IGAN Biosciences, Inc.; Astellas Therapeutics, Inc.; Takeda Pharmaceuticals USA, Inc.; Swedish Orphan Biovitrum AB (publ.); Sarepta Therapeutics, Inc.; Asklepios Biopharmaceutical, Inc.; Massachusetts Institute of Technology; and Shenyang Sunshine Pharmaceutical Co., Ltd.
RNAC (Cartesian Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $247.4M, a beta of 0.56 versus the broader market, a 52-week range of 5.6-15.57, average daily share volume of 215K, a public-listing history dating back to 2016, approximately 66 full-time employees. These structural characteristics shape how RNAC stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.56 indicates RNAC has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a iron condor on RNAC?
An iron condor sells a call spread and a put spread at strikes outside spot, collecting net premium that is kept if the underlying stays inside the inner short strikes.
Current RNAC snapshot
As of May 15, 2026, spot at $7.37, ATM IV 115.70%, IV rank 21.33%, expected move 33.17%. The iron condor on RNAC below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this iron condor structure on RNAC specifically: RNAC IV at 115.70% is on the cheap side of its 1-year range, which means a premium-selling RNAC iron condor collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 33.17% (roughly $2.44 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated RNAC expiries trade a higher absolute premium for lower per-day decay. Position sizing on RNAC should anchor to the underlying notional of $7.37 per share and to the trader's directional view on RNAC stock.
RNAC iron condor setup
The RNAC iron condor below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With RNAC near $7.37, the first option leg uses a $7.74 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed RNAC chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 RNAC shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Sell 1 | Call | $7.74 | N/A |
| Buy 1 | Call | $8.11 | N/A |
| Sell 1 | Put | $7.00 | N/A |
| Buy 1 | Put | $6.63 | N/A |
RNAC iron condor risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the net credit times 100 inside the inner strikes; max loss equals wing width minus credit times 100. Two breakevens at inner strikes plus and minus the credit.
RNAC iron condor payoff curve
Modeled P&L at expiration across a range of underlying prices for the iron condor on RNAC. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use iron condor on RNAC
Iron condors on RNAC are a delta-neutral premium-collection structure that profits if RNAC stock stays inside the inner short strikes; short strikes typically sit near 1 standard deviation from spot.
RNAC thesis for this iron condor
The market-implied 1-standard-deviation range for RNAC extends from approximately $4.93 on the downside to $9.81 on the upside. A RNAC iron condor is a delta-neutral premium-collection structure that pays off when RNAC stays inside the inner short strikes through expiration; the wing width should reflect the trader's tolerance for the maximum loss scenario where the underlying breaches an outer strike. Current RNAC IV rank near 21.33% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on RNAC at 115.70%. As a Healthcare name, RNAC options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to RNAC-specific events.
RNAC iron condor positions are structurally neutral / range-bound; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. RNAC positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move RNAC alongside the broader basket even when RNAC-specific fundamentals are unchanged. Short-premium structures like a iron condor on RNAC carry tail risk when realized volatility exceeds the implied move; review historical RNAC earnings reactions and macro stress periods before sizing. Always rebuild the position from current RNAC chain quotes before placing a trade.
Frequently asked questions
- What is a iron condor on RNAC?
- A iron condor on RNAC is the iron condor strategy applied to RNAC (stock). The strategy is structurally neutral / range-bound: An iron condor sells a call spread and a put spread at strikes outside spot, collecting net premium that is kept if the underlying stays inside the inner short strikes. With RNAC stock trading near $7.37, the strikes shown on this page are snapped to the nearest listed RNAC chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are RNAC iron condor max profit and max loss calculated?
- Max profit equals the net credit times 100 inside the inner strikes; max loss equals wing width minus credit times 100. Two breakevens at inner strikes plus and minus the credit. For the RNAC iron condor priced from the end-of-day chain at a 30-day expiry (ATM IV 115.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a RNAC iron condor?
- The breakeven for the RNAC iron condor priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current RNAC market-implied 1-standard-deviation expected move is approximately 33.17%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a iron condor on RNAC?
- Iron condors on RNAC are a delta-neutral premium-collection structure that profits if RNAC stock stays inside the inner short strikes; short strikes typically sit near 1 standard deviation from spot.
- How does current RNAC implied volatility affect this iron condor?
- RNAC ATM IV is at 115.70% with IV rank near 21.33%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.